Results 121 to 130 of about 8,099 (196)

SBRT: A viable option for treating adrenal gland metastases

, 2015
The management strategy of adrenal metastases depends on different clinical situations. Adrenal metastasectomy in selected patients with isolated adrenal metastases is considered the treatment of choice, showing prolonged survival compared to ...
Ramella, Sara; Department of Radiotherapy, Campus Bio-Medico University, Via Alvaro del Portillo 21, 00128 Rome, Italy, Molfese, Elisabetta; Department of Radiotherapy, Campus Bio-Medico University, Via Alvaro del Portillo 21, 00128 Rome, Italy, Ippolito, Edy, D’Angelillo, Rolando Maria; Department of Radiotherapy, Campus Bio-Medico University, Via Alvaro del Portillo 21, 00128 Rome, Italy, Fiore, Michele; Department of Radiotherapy, Campus Bio-Medico University, Via Alvaro del Portillo 21, 00128 Rome, Italy, Trodella, Lucio; Department of Radiotherapy, Campus Bio-Medico University, Via Alvaro del Portillo 21, 00128 Rome, Italy   +5 more
core   +1 more source

SBRT for lung oligometastases: Who is the perfect candidate?

, 2015
AimTo analyze the literature data about lung oligometastatic patients who underwent SBRT with regard to doses, fractionation, outcomes, response assessment and prognostic factors, trying to define “the right patient” for the local treatment.Background ...
De Rose, Fiorenza, Navarria, Pierina; Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Center, Rozzano (Milano), Italy, Ascolese, Anna Maria; Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Center, Rozzano (Milano), Italy   +2 more
core   +1 more source

Consecutive Daily Versus Every Other Day Stereotactic Body Radiation Therapy Scheduling for Stage I Non-small Cell Lung Cancer

Advances in Radiation Oncology
Purpose: The optimal delivery schedule for stereotactic body radiation therapy (SBRT) in treating stage I non-small cell lung cancer (NSCLC) is unknown.
Yue Lin, MD, Muhammad M. Qureshi, MBBS, MPH, Sonny Batra, MD, Minh-Tam Truong, MD, Kimberley S. Mak, MD, MPH   +4 more
doaj   +1 more source

Safety and Tolerability of SBRT after High Dose External Beam Radiation to the Lung

, 2015
Purpose: Stereotactic body radiotherapy (SBRT) is commonly used to treat unresectable lung nodules. Given its relative safety and effective local control, SBRT has also been used to treat recurrent lung nodules after high dose external beam radiation ...
Robert C. Miller, Paul D. Brown, Limin Song, Limin eSong, Kenneth R Olivier, Kenneth R. Olivier, Sean S. Park, Yolanda I. Garces, Charles S Mayo, Dawn eOwen, Heather eBauer, Robert C Miller, Kathryn eNelson, Daniel J Ma, Paul D Brown, Charles S. Mayo, Kathryn Nelson, Sean S Park, Heather Bauer, Yolanda I Garces, Daniel J. Ma, Dawn Owen   +21 more
core   +1 more source

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases

, 2017
Background In limited metastatic burden of disease, stereotactic body radiotherapy (SBRT) has been shown to achieve high local control rates. It has been hypothesized that SBRT may translate to a better quality of life by delaying the need for systemic ...
Jeremy Hamm, Mitchell Liu, Devin Schellenberg, Rosanna Yeung   +3 more
core   +1 more source

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience

Radiation Oncology
Background Standard treatment options for patients with metastatic urothelial cancer (mUC) include systemic platinum-based chemotherapy, immunotherapy, antibody-drug-conjugates, and targeted therapy.
Fernanda Costa Svedman, Karin Holmsten, Faith Jawdat, Wehazit Hailom, Daniel Alm, Vitali Grozman, Anders Ullén   +6 more
doaj   +1 more source

Radiographic Response and Clinical Toxicity Following SBRT for Stage I Lung Cancer

, 2007
Clinical outcomes following stereotactic body radiation therapy (SBRT) for stage I non-small cell lung cancer (NSCLC) are excellent, with local control rates ranging from 80% to 95% in medically inoperable patients. Toxicity following SBRT has been lower
Bradley, Jeffrey
core   +1 more source

ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial

Background: Metastasis-directed therapy by stereotactic body radiotherapy (SBRT) has been shown to improve clinical outcomes in the oligometastatic prostate cancer setting.
Mistretta F. A., Palma D. A., Corrao G., Burla T., Zaffaroni M., Orecchia R., Gandini S., De Cobelli O., Ost P., Luzzago S., Mazzocco K., Fusco N., Netti S., Cursano G., Musi G., Petralia G., Lorubbio C., Tang C., Cattani F., Marvaso G., Fodor C., Vincini M. G., Pravettoni G., Zerini D., Venetis K., Jereczek-Fossa B. A.   +25 more
core   +1 more source

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer

, 2012
Background: Fatigue is a common side-effect of conventional prostate cancer radiation therapy. The increased delivery precision necessitated by the high dose per fraction of stereotactic body radiation therapy (SBRT) offers the potential of reduce ...
Chiranjeev eDash, Heather N Hanscom, Joy S. Kim, Sean eCollins, Jennifer Sween, Lucile L Adams-Campbell, Sean Collins, Simeng eSuy, Heather N. Hanscom, Lucile L. Adams-Campbell, Joy S Kim, Jennifer eSween, Sunghae Uhm, Kimberly M. Davis, Sunghae eUhm, Simeng Suy, Chiranjeev Dash, Kristina Demas, Kimberly M Davis, Kristina eDemas   +19 more
core   +1 more source

Challenging Situations for Lung SBRT [PDF]

Journal of Thoracic Oncology, 2017
Daniel, Przybysz, Jeffrey D, Bradley
openaire   +2 more sources